+ All Categories
Home > Documents > Introduction of Cancer Molecular Epidemiology Epidemiology 243 Zuo-Feng Zhang, MD, PhD University of...

Introduction of Cancer Molecular Epidemiology Epidemiology 243 Zuo-Feng Zhang, MD, PhD University of...

Date post: 20-Jan-2016
Category:
Upload: monica-whitehead
View: 227 times
Download: 0 times
Share this document with a friend
Popular Tags:
23
Introduction of Cancer Molecular Epidemiology Epidemiology 243 Zuo-Feng Zhang, MD, PhD University of California Los Angeles
Transcript
Page 1: Introduction of Cancer Molecular Epidemiology Epidemiology 243 Zuo-Feng Zhang, MD, PhD University of California Los Angeles.

Introduction of Cancer Molecular Epidemiology

Epidemiology 243

Zuo-Feng Zhang, MD, PhDUniversity of California Los Angeles

Page 2: Introduction of Cancer Molecular Epidemiology Epidemiology 243 Zuo-Feng Zhang, MD, PhD University of California Los Angeles.

Numbers of Papers with Subject Words “Molecular Epidemiology” on Medline

0

500

1000

1500

2000

2500

3000

60-69 80-84 90-94 00-04

Paper/year

70-79 80-84 90-94 05-09

Page 3: Introduction of Cancer Molecular Epidemiology Epidemiology 243 Zuo-Feng Zhang, MD, PhD University of California Los Angeles.

Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K. NEJM, 2000

Page 4: Introduction of Cancer Molecular Epidemiology Epidemiology 243 Zuo-Feng Zhang, MD, PhD University of California Los Angeles.

Definition of Epidemiology

Epidemiology:• Describe distribution patterns of the disease

among population, time trend, and places• Identify determinants (risk

factors/etiological factors) of the disease• Disease prevention and control: conduct

intervention studies to reduce incidence and mortality of the disease

Page 5: Introduction of Cancer Molecular Epidemiology Epidemiology 243 Zuo-Feng Zhang, MD, PhD University of California Los Angeles.

Epidemiology and Molecular Sciences

Epidemiology Molecular Sciences

• Health effects in grouped people

• Observation and inference of association between variables

• Macro

• Assessment of the individual at the component level

• Experimental proof of cause and effects

• Micro

Page 6: Introduction of Cancer Molecular Epidemiology Epidemiology 243 Zuo-Feng Zhang, MD, PhD University of California Los Angeles.

Evolution of General Epidemiology

• Advances in molecular biology, genetics, analytical chemistry, and other basic sciences have made it possible to measure contaminants, carcinogens, biological changes at a much smaller level.

• These advances can assist us to assay genetic susceptibility by genotyping and other genetic methods and to identify mechanisms at cellular and molecular levels

Page 7: Introduction of Cancer Molecular Epidemiology Epidemiology 243 Zuo-Feng Zhang, MD, PhD University of California Los Angeles.

Revolution in Molecular Biology:

• Science• Medicine• Human Genetics

• Public Health• Epidemiology• Chemistry

Molecular Epidemiology

Page 8: Introduction of Cancer Molecular Epidemiology Epidemiology 243 Zuo-Feng Zhang, MD, PhD University of California Los Angeles.

Molecular Epidemiology

• The goal of molecular epidemiology is to supplement and integrate, not to replace, existing methods

• Molecular epidemiology can be utilized to enhance capacity of epidemiology to understand disease in terms of the interaction of the environment and heredity.

Page 9: Introduction of Cancer Molecular Epidemiology Epidemiology 243 Zuo-Feng Zhang, MD, PhD University of California Los Angeles.

Traditional and Molecular Epidemiology

Traditional Molecular• Association• High exposure and

single outcome• Prevention through

control of exposure is feasible without understanding cellular process

• Mechanisms• Smaller and mixed

exposures; multicausal• Intervention through

cellular process has the need to understand mechanisms of the process

Page 10: Introduction of Cancer Molecular Epidemiology Epidemiology 243 Zuo-Feng Zhang, MD, PhD University of California Los Angeles.

Molecular Epidemiology

• studies utilizing biological markers of exposure, disease and susceptibility

• studies which apply current and future generations of biomarkers in epidemiologic research.

Page 11: Introduction of Cancer Molecular Epidemiology Epidemiology 243 Zuo-Feng Zhang, MD, PhD University of California Los Angeles.

Basics of Molecular Epidemiology

• The term of molecular epidemiology indicates the incorporation of molecular, cellular, and other biological measurements into epidemiologic studies

Page 12: Introduction of Cancer Molecular Epidemiology Epidemiology 243 Zuo-Feng Zhang, MD, PhD University of California Los Angeles.

Biological Markers: Definition of Biological Markers

Biological markers can be currently defined as a biological product related to any sequence of multistage carcinogenesis, including tumor initiation and promotion.

Page 13: Introduction of Cancer Molecular Epidemiology Epidemiology 243 Zuo-Feng Zhang, MD, PhD University of California Los Angeles.

Biological Markers Measurement of Biomarkers

Biomarkers can be measured quantitatively or qualitatively by biochemical, immunochemical, cytogentic, molecular and genetic techniques.

Page 14: Introduction of Cancer Molecular Epidemiology Epidemiology 243 Zuo-Feng Zhang, MD, PhD University of California Los Angeles.

Biological Markers: Materials for Biomarker Measurement

Biomarkers can be measured in human biological materials including normal and tumor tissues, blood and urine sample, etc.. Their biological nature can be DNA, RNA, and protein, etc.

Page 15: Introduction of Cancer Molecular Epidemiology Epidemiology 243 Zuo-Feng Zhang, MD, PhD University of California Los Angeles.

Biological Markers:The Application of Biomarkers

• Biomarkers can be employed to predict primary or secondary cancer risk, to establish cancer burden, to further classify the tumor in addition to pathological classification, to predict tumor prognosis, to determine treatment strategy, and to evaluate chemo-prevention or intervention.

Page 16: Introduction of Cancer Molecular Epidemiology Epidemiology 243 Zuo-Feng Zhang, MD, PhD University of California Los Angeles.

Capacities of Molecular Epidemiology

• Identification of Exposure at the smaller scale• Identification of events earlier in the nature history

of disease• Assay susceptibility markers and evaluation of

gene-environment interaction• In addition, it can be used to reduce

misclassification, to indicate mechanisms, and enhance risk assessment

Page 17: Introduction of Cancer Molecular Epidemiology Epidemiology 243 Zuo-Feng Zhang, MD, PhD University of California Los Angeles.

Molecular Epidemiology

• These capacities provide additional tool for epidemiologists studying questions on etiology, prevention and control of diseases

• Although molecular epidemiology can be viewed as an evolution step of epidemiology, it generally dose not represent a shift in the basic paradigm of epidemiology

Page 18: Introduction of Cancer Molecular Epidemiology Epidemiology 243 Zuo-Feng Zhang, MD, PhD University of California Los Angeles.

Study of Black Box

The concept of a continuum of events between exposure and disease provide opportunities

• To ensure that epidemiologic research has a biological basis for hypothesis

• To provide the analysis to test these ideas• To generate new epidemiological methods

to deal with new challenges

Page 19: Introduction of Cancer Molecular Epidemiology Epidemiology 243 Zuo-Feng Zhang, MD, PhD University of California Los Angeles.
Page 20: Introduction of Cancer Molecular Epidemiology Epidemiology 243 Zuo-Feng Zhang, MD, PhD University of California Los Angeles.

Application: Risk Assessment

Molecular epidemiology focuses on identifying high risk individuals and make personalized risk assessments by measuring changes at molecular level, particularly those entailing structure gene damage, gene variation, or the measurement of gene products in cells and body fluids

Page 21: Introduction of Cancer Molecular Epidemiology Epidemiology 243 Zuo-Feng Zhang, MD, PhD University of California Los Angeles.

Application: Genetic Predisposition or Susceptibility

Molecular epidemiology utilizes a series of biological markers (exposure, susceptibility, early biological response markers), which include genetic predisposition and susceptibility markers which are usually the major focus of the genetic epidemiology.

Page 22: Introduction of Cancer Molecular Epidemiology Epidemiology 243 Zuo-Feng Zhang, MD, PhD University of California Los Angeles.

The application of Biomarkers

• Biomarkers can be employed in primary preventive or etiological research by detecting the relationship between environmental exposure and specific mutations.

• These can be utilized in secondary preventive studies or early detection and diagnosis by identifying markers for tumors at early stage or precursor of tumor.

• Finally, these markers can be used in tertiary preventive studies or prediction of prognosis by correlating biomarkers with tumor progression and patient survival.

Page 23: Introduction of Cancer Molecular Epidemiology Epidemiology 243 Zuo-Feng Zhang, MD, PhD University of California Los Angeles.

Tasks for Molecular Epidemiologist

The major tasks are • to reduce misclassification of exposure, • to assess effect of exposure on the target tissue, • to measure susceptibility/inherited predisposition

to cancer, • to establish the link between environmental

exposures and gene mutations, • to assess gene-environment interaction. • To set up prevention/intervention strategies.


Recommended